Skip to main navigation
Skip to search
Skip to main content
Experts@Minnesota Home
Home
Profiles
Research units
University Assets
Projects and Grants
Research output
Datasets
Press/Media
Activities
Fellowships, Honors, and Prizes
Impacts
Search by expertise, name or affiliation
Immunovirotherapy for the treatment of glioblastoma
Tooba A. Cheema
, Peter E. Fecci
,
Jianfang Ning
, Samuel D. Rabkin
Research output
:
Contribution to journal
›
Article
›
peer-review
18
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Immunovirotherapy for the treatment of glioblastoma'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Glioblastoma
100%
Interleukin-12 (IL-12)
100%
Immunovirotherapy
100%
Syngeneic
50%
Genetic Modification
50%
Murine Model
50%
Human Disease
50%
Immunodeficient Mice
50%
Immunological Characteristics
50%
Glioma Stem Cells
50%
Histopathological Features
50%
Oncolytic Herpes Simplex Virus (oHSV)
50%
Immunology and Microbiology
Oncolytic Herpes Virus
100%
Syngenic
100%
Stem Cell
100%
Interleukin 12
100%
Neuroscience
Stem Cell
100%
Interleukin 12
100%
Oncolytic Herpes Virus
100%
Medicine and Dentistry
Glioblastoma
100%
Stem Cell
33%
Interleukin 12
33%
Oncolytic Herpes Virus
33%
Diseases
33%